Bill Primrose, CEO, Ripptide Pharma




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Bill Primrose, CEO, Ripptide Pharma
Released on: January 12, 2016. © PharmaVentures Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Bill Primrose describes his macrocycle technology, and it’s protein-protein interaction "sweet spot" across a range of therapy areas.
  • Summary
  • Participants
  • Company
Bill Primrose describes his macrocycle technology, and it’s protein-protein interaction "sweet spot" across a range of therapy areas.
Bill Primrose
Ripptide Pharma has developed a chemoenzymatic process for the efficient production of macrocycles and cyclic peptides, addressing entirely novel areas of chemical space for drug discovery and development.